Physician

Andrew Steven Gahagan, MD

According to 2025 Medicare claims, Andrew Gahagan, MD (NPI: 1609372812) practices hematology/oncology in the Baton Rouge, LA market, with the plurality of this provider's patient population coming from Ascension, LA. This provider's primary affiliated billing organization is MARY BIRD PERKINS CANCER CENTER (NPI: 1295833580; TIN: 237010520) and primary practice location at 70809-3482.

Gahagan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 55 traditional Medicare patients, billed 2,755 HCPCS/CPT codes, and received $65,788 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 231 prescription claims across 72 beneficiaries totaling $231,550 in drug costs, led by Prochlorperazine Maleate (Prochlorperazine Maleate). Open Payments data shows 27 records totaling $746. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $763 to $231,550. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$33K$66K2024 Medicare payment: $65,788 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024552,755$65,788

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$116K$232K2018 Drug cost: $763 (USD; Tot_Drug_Cst)2019 Drug cost: $6,103 (USD; Tot_Drug_Cst)2020 Drug cost: $9,523 (USD; Tot_Drug_Cst)2021 Drug cost: $1,022 (USD; Tot_Drug_Cst)2022 Drug cost: $16,990 (USD; Tot_Drug_Cst)2024 Drug cost: $231,550 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181133$763
20191159$6,103
20202281$9,523
2021N/R28$1,022
20221115$16,990
2023N/RN/RN/R
202472231$231,550

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more1616$164
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more2258$130
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes1317$130
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1827$95

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prochlorperazine MaleateProchlorperazine Maleate16280$295
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen12257$277
LoperamideLoperamide Hcl13275$140
PrednisonePrednisone11186$11

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.27$746ADC Therapeutics America, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Andrew Steven Gahagan, MD?

Tedicare shows public-source Medicare data for Andrew Steven Gahagan, MD (NPI 1609372812), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew Steven Gahagan, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Andrew Steven Gahagan, MD?

Andrew Steven Gahagan, MD is linked to MARY BIRD PERKINS CANCER CENTER (billing NPI 1295833580) in the available physician profile data.

Does Andrew Steven Gahagan, MD have Open Payments data?

Andrew Steven Gahagan, MD has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.